Cepheid
✓ VerifiedMolecular diagnostics and rapid testing systems
📊
$1,200M
Annual Revenue
👥
3200
Employees
📦
35
Products
91%
91%
Profile Completeness
📄 About Cepheid
Cepheid (a Danaher company) develops the GeneXpert platform for rapid molecular diagnostics, enabling point-of-care testing for infectious diseases including COVID-19 and TB.
🛡️
High Quality
Products
Products
🌐
Global
Distribution
Distribution
💡
Innovative
Technology
Technology
👥
Customer
Focused
Focused
📦 Featured Products
View All Products →
No products currently listed for Cepheid.
📍 Location & Offices
View on Map
🗺️
Sunnyvale, United States
📋 Request a Quote
Send your requirements directly to Cepheid. Response typically within 48 hours.
